Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Taiwan Bio Therapeutics Co., Ltd. (6892) Financial Statements

Taiwan Bio Therapeutics Co., Ltd. Financial Overview

Taiwan Bio Therapeutics Co., Ltd.'s market cap is currently NT$2.44B. The company's EPS TTM is NT$-5.15; its P/E ratio is -5.73; Taiwan Bio Therapeutics Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 50.43MNT$ 105.09MNT$ 85.47MNT$ 44.74MNT$ 27.16M
Gross ProfitNT$ 32.14MNT$ 56.07MNT$ 76.36MNT$ 31.67MNT$ 22.65M
Operating IncomeNT$ -385.33MNT$ -351.44MNT$ -212.20MNT$ -182.60MNT$ -87.34M
EBITDANT$ -259.98MNT$ -247.39MNT$ -145.97MNT$ -129.47MNT$ -58.44M
Net IncomeNT$ -381.65MNT$ -351.80MNT$ -217.51MNT$ -188.56MNT$ -90.20M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 290.39MNT$ 677.69MNT$ 248.14MNT$ 245.89MNT$ 59.70M
Total AssetsNT$ 1.35BNT$ 1.47BNT$ 941.76MNT$ 871.01MNT$ 590.13M
Total DebtNT$ 318.71MNT$ 316.05MNT$ 268.62MNT$ 286.56MNT$ 291.26M
Net DebtNT$ 28.32MNT$ -361.64MNT$ 20.48MNT$ 40.67MNT$ 231.56M
Total LiabilitiesNT$ 625.12MNT$ 380.58MNT$ 328.47MNT$ 344.18MNT$ 333.63M
Stockholders' EquityNT$ 729.60MNT$ 1.09BNT$ 613.29MNT$ 526.83MNT$ 256.50M
Cash Flow
Free Cash FlowNT$ -244.42MNT$ -363.25MNT$ -285.78MNT$ -223.16MNT$ -233.85M
Operating Cash FlowNT$ -212.31MNT$ -252.40MNT$ -166.55MNT$ -139.99MNT$ -59.16M
Investing Cash FlowNT$ -152.89MNT$ -104.52MNT$ -119.23MNT$ -103.17MNT$ -178.97M
Financing Cash FlowNT$ -26.68MNT$ 786.01MNT$ 290.43MNT$ 429.35MNT$ 261.33M

Currency in TWD

Taiwan Bio Therapeutics Co., Ltd. Earnings and Revenue History

-500M-250M0250M-800 %-600 %-400 %-200 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Taiwan Bio Therapeutics Co., Ltd. Liabilities to Assets

0600M1.2B1.8B20 %40 %60 %80 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Taiwan Bio Therapeutics Co., Ltd. Cash Flow

-500M-250M0250M500M750M1B2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Taiwan Bio Therapeutics Co., Ltd. Forecast EPS vs Actual EPS

Earnings >